Q4 2018 Pipeline

1) Partner with Eisai on BAN2401 for treatment of Alzheimer’s Disease. Eisai partnered with Biogen on BAN2401 in 2014
2) Dementia and cognitive impairment associated with Down’s syndrome and Traumatic Brain Injury

BioArctic’s portfolio has projects in several therapy areas and in various phases from discovery to clinical development. Project portfolio per December 31, 2018.